Target intelligence / Profile preview

Intestinal motility stimulation via osmotic effect

Molecular classification
Other
01

Overview

"Intestinal motility stimulation via osmotic effect" is **not a single molecule or receptor**, but rather describes a physiological process by which certain substances increase the movement of the intestines. This occurs when nonabsorbable solutes (such as mannitol or lactulose) are present in the gut lumen at high concentrations. These substances create an **osmotic gradient** that draws water into the intestine, causing distension. The resulting stretch stimulates local sensory mechanisms—likely involving osmoreceptors and mechanoreceptors—in the duodenal wall, particularly within the first 10 cm[1]. This triggers neural reflexes that enhance smooth muscle contractions and promote peristalsis.\n\nThis process is exploited therapeutically by **osmotic laxatives** like mannitol and lactulose to treat constipation. However, "intestinal motility stimulation via osmotic effect" does *not* refer to any specific protein target such as an enzyme or receptor; it is instead an indirect mechanism involving physical properties of solutes acting on physiological sensors within gut tissue[1][2].\n\nTherefore, this entry should be flagged as incorrect for use as a canonical drug target name—it describes a mechanism rather than an identifiable molecular entity suitable for structured pharmacological targeting.

Other names
Intestinal motility stimulation via osmotic effectOsmotic stimulation of intestinal motilityOsmotic laxative mechanism (contextual, not a molecular target)
02

Mechanism of action

Increases luminal osmolarity to draw water into the intestinal lumen, leading to distension and stimulation of local osmoreceptors or mechanoreceptors that trigger increased intestinal motility[1][2]

03

Biological functions

Regulation of gastrointestinal motilityWater and electrolyte balance in the gutInduction of peristalsis (via indirect mechanisms)
04

Disease associations

Other (primarily used in constipation and bowel preparation, not directly implicated as a disease target)
05

Safety considerations

Electrolyte imbalance (e.g., dehydration, hyponatremia)Abdominal cramping or bloating\n(known for all osmotic laxatives; not specific to a molecular target)
06

Interacting drugs

Mannitol[1]

2 more in the full profile.

Beyond the preview

Go deeper on Intestinal motility stimulation via osmotic effect.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal motility stimulation via osmotic effect.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call